A sequence compilation and comparison of exons that are alternatively spliced in neurons by Stamm,  S. et al.
© 1994 Oxford University Press Nucleic Acids Research, 1994, Vol. 22, No. 9 1515-1526
A sequence compilation and comparison of exons that are
alternatively spliced in neurons
Stefan Stamm*, Mike Q.Zhang, Thomas G.Marr and David M.Helfman
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
Received January 28, 1994; Accepted March 16, 1994
ABSTRACT
Alternative splicing is an important regulatory
mechanism to create protein diversity. In order to
elucidate possible regulatory elements common to
neuron specific exons, we created and statistically
analysed a database of exons that are alternatively
spliced in neurons. The splice site comparison of alter-
natively and constitutively spliced exons reveals that
some, but not all alternatively spliced exons have splice
sites deviating from the consensus sequence, implying
diverse patterns of regulation. The deviation from the
consensus is most evident at the - 3 position of the
3' splice site and the + 4 and - 3 position of the 5'
splice site. The nucleotide composition of alternatively
and constitutively spliced exons is different, with
alternatively spliced exons being more AU rich. We
performed overlapping k-tuple analysis to identify
common motifs. We found that alternatively and
constitutively spliced exons differ in the frequency of
several trinucleotides that cannot be explained by the
amino acid composition and may be important for
splicing regulation.
INTRODUCTION
Among all animal tissues the brain is probably the most
molecularly complex organ with about 30% of the mammalian
genome expression dedicated to it [1]. Both kinetic [2] and clonal
[3] analysis indicate that 40-65% of the mRNA expressed in
brain is restricted to this tissue. Furthermore, the majority of
this mRNA is expressed in neurons and not in glia [4], [5].
Neuron specific gene expression can be achieved by
transcriptional (reviewed in [5, 6]) and post transcriptional
mechanisms including splicing and RNA editing [7]. In order
to analyze common features of neuron specific exons, we
compiled and analyzed the currently available neuron specific
exons.
It has been estimated that alternative splicing is involved in
more than 5% of on/off regulation in Drosophila genes [8]. In
addition, it has been shown that the inclusion of alternatively
spliced exons alters the electrophysiological properties of ion
channels like the the Glutamine A - D [9] and the NMDA [10]
receptors. In 11 genes listed in this survey, alternatively spliced
exons encode stop codons leading to truncated proteins. In 10
genes listed, the alternatively spliced exon introduces a
phosphorylation site and in one case a phosphorylation site is
removed.
The exact mechanisms that regulate the alternative use of
neuron specific exons are not well understood. Several regulatory
sequences have been identified, including splice sites deviating
from the consensus [11], RNA binding factors [12, 13], elements
in the flanking introns [14, 15] and secondary structures [16].
In addition, several components of the splicing machinery have
been found to be specific for neurons, among them the
composition of SR proteins [ 17], U2 RNA composition [18] and
the protein SmN [19] that might be involved in the etiology of
the Prader Willi syndrome [20], but whose functional significance
is not clear [21].
Neuron specific alternatively spliced exons can be the result
of neuron specific transcription followed by alternative splicing,
or the result of transcription that takes place in all cells followed
by neuron specific splicing. Although the consequence in both
cases is an exon that is alternatively spliced in neurons, the
mechanistic regulation might be quiet different. For example,
neuron specific exons generated by neuron specific promoter use
are alternatively regulated in non-neuronal cells [22]. In contrast,
several genes exhibit neuron specific splicing only when
expressed in neuronal cells, but not in any other cell type [11],
[15, 23]. The neuron-specific usage of the exons compiled here
has been established by comparison with some, but not all, non-
neuronal tissues like liver or muscle. Therefore, more detailed
investigations may detect some use of these exons in non-neuronal
cell types. Furthermore, inspection of the compiled sequences
shows that certain functional subclasses such as receptors are
highly represented, which probably reflects the current focus of
research on these molecules, rather than their greater use of
alternative spliced exons.
METHODS
Collection of alternative spliced exons and control database
Exons that are alternatively spliced in neurons were collected
from the literature using the Medline database, searching with
the key words 'alternative splicing' and 'brain' or 'neuron'. The
sequences were run against GenBank using the BLASTN 1.3.12
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Table 1. Compilation of exons that are alternatively spliced in neurons
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Regional distribution indicates the alternative splicing is different in the various regions of the brain. Developmental regulation indicates a regulation
during embryonic and early postnatal development. Experimental evidence lists the experimental methods employed to determine the specificity
(in situ: RNA in situ hybridisation). If the alternative spliced exons were found to a lesser extent in other tissues, it is indicated under 'experimental
evidence'. A '@' sign in the sequences indicates the beginning of a codon. The species are abbreviated as follows: R: rat, M: mouse, H: human,
D: drosophila, B: bovine, C: chicken, F: fish. The accession number refers to GenBank. Exon sequences are indicated by capital letters, intron
sequences by small letters.
program (NCBI) [24] to find related sequences and entry errors.
Vertebrate internal exons and their corresponding downstream
donor sites were obtained from the Geneld-datasets [25]. The
vertebrate acceptor sites were kindly provided by Dr Knudsen
(CEDB, West Florida). In order to produce scores for the
combined 5' and 3' splice sites, we randomly selected 200
Genbank (80.0, 12/10/93) vertebrate splice site pairs that flank
constitutively spliced exons. cDNA sequences upstream and
downstream of the alternatively spliced exons were extracted from
Genbank as control sequences for constitutively spliced exons.
LOG-ODD scores were calculated according to Zhang and
Marr [26] using the Geneld dataset and randomly extracted splice
sites as a comparison. The scoring function is defined as:
= lOg2 7T
Pi(X) is the frequency of finding X at position i that is equal to
Cj(X)/Dj The normalization D, is the sum of the counts C,(X)
over X (=A,C,G,T). We used Q(X) = 1/4 for all X as the random
background frequency. The score for a splice site is the sum of
the scores for each individual nucleotide.
RESULTS AND DISCUSSION
Different classes of alternatively spliced exons in neurons
The different classes of alternatively spliced exons are shown
in Table 1. They were arranged according to their gene structure,
gene expression and splicing pattern. The splicing pattern is
schematically indicated on top of each class. Exons that introduce
known regulatory elements like phosphorylation sites, stop codons
or frameshifts are listed at the end of each list. The reading frame
is indicated by a '@'. The regulation of the alternative splicing,
the expression pattern and the experimental techniques used to
analyse the alternative exons are included if such information
was available in the literature.
Splice site analysis
The nucleotide composition of splice sites surrounding
alternatively spliced exons has been shown to be important for
their alternative use [27]. The deviation of splice sites from the
consensus sequence [28] seems to decrease binding of splicing
factors around the alternatively spliced exon and to limit its use.
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Figure 1. Nucleotide usage at the 5' splice site. The percent nucleotide usage
of constitutively (left) and neuron specific alternatively spliced exons (right) is
pairwise compared. The Ul sequence and the vertebrate consensus splice site
sequence are shown at the bottom. The different nucleotides are indicated by
different patterns, as indicated in the figure.
binding have been shown to decrease the usage of exons [29,
30]. The composition of the 3' splice site [31] and the branch
point has been shown to be important. However, the splice sites
of alternative exons do not always deviate from the consensus.
For example, the splice sites surroundng the exons coding for
substance P [16], sexlethal and the Drosophila P element [8]
match the consensus sequence.
General 5' splice site composition
The 5' splice site consensus sequence reflects base pairing with
Ul snRNA. A comparison of 5' splice sites from common and
neuron specific alternatively spliced exons is shown in Figure
1. On average, neuron specific 5' splice sites deviate most from
the consensus at the +3 and - 4 position, where the consensus
nucleotide is present 40% less often than in constitutive exons.
In position +2, + 1 , and - 3 use of the consensus nucleotide
is increased by 8%, at the position —5 it is decreased by 16%
and at - 6 it is increased by 26%. Addition of these percentages
shows that neuron specific 5' splice sites overall use 49% fewer
consensus nucleotides complementary to Ul snRNA. However,
this deviation is not equally distributed. Most deviation takes place
at two positions, +3 (consensus: C) and —4 (consensus: A).
Whether this uneven distribution has functional significance has
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to be determined. The nucleotide at the —4 position has been
postulated to interact with A49 of the U6 snRNA in a late step
in splicing [32, 33]. Compared to constitutive 5' splice sites,
alternatively spliced neuronal 5' splice sites have fewer A, but
more U at this position, thus on average binding of their 5' splice
sites with U6 snRNA might be facilitated. It is interesting to note
s
y y y y y y y y y y y y C a g C
-3 -2 "I +1
Figure 2. Nucleotide usage at the 3' splice site. The percent nucleotide usage
of constitutively (left) and neuron specific alternatively spliced exons (right) is
pairwise compared. The vertebrate consensus sequence is indicated at the bottom,
exon sequences are in capital letters. Note the use of A in alternately spliced
exons at the - 3 position. The different nucleotides are indicated using the same
patterns as in Figure 1.
that the consensus nucleotide at the —4 position in yeast is also
U, but the significance of this similarity is unclear.
General 3' splice site composition
The comparison of the 3' splice sites from neuron specific
alternatively spliced exons and common exons reveals differences
at the - 3 position (Figure 2). Twenty one percent of all neuron-
specific exons use an A at this position, compared to only 4%
in constitutively used 3' splice sites. The reason why a pyrimidine
is conserved at the - 3 position is not clear. However, it has been
demonstrated that a C - A mutation at this position reduces
splicing efficiency by 70% [30]. In addition, in each but the -14
position, neuron specific 3' splice sites have a higher purine
content when compared with constitutive 3' splice sites.
Evaluation of splice sites using LOG-ODD scores
In order to assess the splice site quality, we calculated
LOG-ODD scores for each splice site. The LOG-ODD scores
express the coincidence of a splice site with the consensus
sequence; a higher coincidence generates a higher score. We first
calculated a score for each alternative splice site and compared
the distribution of individual scores with constitutively spliced
exons. Since it has been postulated that the splice sites
surrounding an exon define its borders in a concerted way [34],
we then calculated the LOG—ODD scores for the splice sites
combined splice sites I
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Figure 3. Distribution of splice sites scores in neuron specific and consitutivly spliced vertebrate exons. The scores are plotted on the x-axis, the higher the score
the better is the match to the consensus sequence. The number of splice sites that accompany a certain score are plotted on the y-axis. Neuron-specific exons are
shaded. A. Distribution of neuron-specific 5' splice sites. B. Distribution of common 5' splice sites. A perfect match to Ul would have a score of 12.2. The mean
of the distribution is 7.1 for neuron specific exons and 8.0 for constitutively spliced exons. C. Distribution of neuron-specific 3' splice sites. D. Distribution of
common 3' splice sites. A 'perfect' 3 ' splice site (u)McagG would have a score of 15.6. The mean of the distribution is 5.7 for neuron specific exons and 9.4 for
constitutively spliced exons. E. Distribution of combined scores of 5' and 3 ' splice sites that surround an neuron-specific exon F. Distribution of combined scores
of 5' and 3' splice sites that surround an common exon. An exon surrounded by a 'perfect' 3' and 5' splice site would have a score of 27.8. The mean of the
distribution is 12.2 for neuron specific exons and 16.9 for constitutively spliced exons.
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surrounding one exon. Compared to the control splice sites, the
distribution of alternative donor and acceptor splice sites is
broader and the mean of the distribution is at a lower score
(Figure 3, A and B). This could indicate the presence of two
subclasses of splice sites in alternatively spliced exons, with one
subclass having the splice sites in consensus and the other subclass
having sub-optimal splice sites. When the splice sites surrounding
one individual exon are considered, the presence of two subclasses
becomes more apparent (Figure 3, E and F). One group of
alternatively spliced exons has splice sites that are sub-optimal,
whereas another group has splice sites that score similar to the
splice sites of constitutively spliced exons. This could mean that
the first group of exons is most likely regulated by their splice
site quality, which is in agreement with the exon definition model
[34]. Skipping of these exons is the most likely default
mechanism. The second group is most likely regulated by other
elements like steric hindrance [15], secondary structures [16] or
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Figure 4. Trinucleotide and amino acid distribution in neuron specific (shaded) and constitutively spliced exons (open). A. Distribution of overlapping 3-tupIes in
alternatively and constitutively spliced exons. The actual nucleotide distribution of altemativly and constitutivly exons was used to calculate the random nucleotide
distribution by random shuffling, the means and the double standard deviations of these random samples are plotted as dots and error bars. Columns indicate the
actual percent usage of each 3-tuple. B. Distribution of amino acids in alternatively and constitutively spliced exons. The percent usage of each amino acid is indicated.
The error bars indicate the standard deviation.
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Nucleotide composition of alternative spliced exons and
possible motifs
We analysed the nucleotide composition of the alternatively
spliced exons to assess its possible role in exon usage. Overall,
alternatively spliced exons are more AU-rich (26%A, 27% C,
24%G, 23% U) than common exons (25%A, 28% C, 27%G,
20% U). The p-values [36] calculated for the differences of the
A, C, G, and U values are 0.015, 0.106, 2.97xl0~12 and
4 .68x l0~" , respectively. Therefore, the null hypothesis that
the nucleotide composition in constitutively and alternately
spliced exons are the same should be rejected at the 0.05
significance level for all nucleotides except C. We conclude from
this statistical analysis that the differences in nucleotide
composition are significant.
Since several groups reported the involvement of exon motifs
in recognition of alternatively spliced exons [13, 37—47] we
analysed the neuron specific exon database for k-tuple frequencies
according to Claverie et al. [48]. The overlapping 3-tuple
distributions in both alternatively and constitutively spliced exons
are plotted in Figure 4, A. The expected frequencies and the
dispersions for random sequences with the same nucleotide
compositions were calculated by randomizing each data set and
are indicated as error bars in Figure 4, A. The general feature
for all exons is the rare use of TA and CG dinucleotides as shown
by the deviation below the random expectations, possibly to avoid
termination and methylation. Assuming that the nucleotides
assemble independently of each other, most of the differences
in 3-tuple frequencies between the two exon data sets can be
explained by the single nucleotide composition, because the
3-tuple frequencies follow the trend of the random expectations.
However, some of the major differences cannot simply be
attributed the single nucleotide composition, for example the
relative high frequency of trinucleotides AAA and TTT in
alternatively spliced exons cannot be explained by the single
nucleotide composition and by the amino acid composition of
the alternately spliced exons (Figure 4, B).
In common exons, the trinucleotides CAG, CTG, AGA, TGG
and GAG are more frequent than what would be expected in a
random assembly. Their high frequency cannot be explained by
the amino acid composition of the common exons (Figure 4, B),
because only the amino acids F, S, W, Y could contribute to
a 3-tuple frequency difference but except F these differences are
not correlated to the different trinucleotide distribution. We
therefore assume that constraints that lead to the different 3-tuple
distribution are due to regulatory requirements on the RNA level.
We furthermore conclude that the different 3-tuple composition
of alternatively and constitutively spliced exons might have
regulatory significance in splicing.
The high frequency of certain trinucleotides probably represents
the general characteristics of common exons. In order to see how
these 3-tuples are distributed in alternatively spliced exons, we
computed the 3-tuple frequency per sequence for the neuron
specific exons (each 3-tuple counts at most once in each exon),
CAG and AGA were found to be the most frequent, with more
than 89% of the alternatively spliced exons containing either CAG
or AGA (data not shown).
In order to find motifs common in alternatively spliced exons,
we used the RTide program which was designed to search short
motifs in multi-sequences [49]. We were unable to identify a motif
in the exon sequences or in subset of these sequences. However,
our RTide analysis indicated that CAGA might be part of possible
motifs in alternatively spliced exons.
The AU rich nucleotide composition and the distribution of
tri and tetranucleotides in alternatively spliced exons is in contrast
to several AG rich sequence motifs that have been described as
necessary for alternative exon usage [38-40, 42, 43, 45-47].
It is tempting to speculate that the AG rich motifs that are in
an AU rich context of the alternatively spliced exons serve as
signals for the splicing machinery, presumably through binding
to an hnRNP. In the light of our analysis, the mutation of these
motifs leads to skipping of the alternative exon, because different
or no trans factors are now binding to the mutant exon and make
it recognizable to the splicing machinery.
Since rapid progress is being made in sequencing and
identifying neuron specific exons, we hope that in future updates
of this sequence comparison putative motifs will become more
clear.
Update
Since we are planning to update this compilation in the future,
we would be thankful for the communication of new or here
omitted neuron specific exons. Furthermore, the sequences can
be obtained electronically either from stamm@cshl.org or by
anonymous ftp from phage.cshl.org in the /pub/science/alt exon
directory.
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